Cargando…

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk

BACKGROUND: Tacrolimus (Tac) intraindividual variability (TacIPV) in pediatric kidney transplant patients is only poorly understood. We investigated the impact of TacIPV on de novo donor-specific HLA antibodies (dnDSA) development and allograft rejection in Caucasian pediatric recipients of a living...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baghai Arassi, Maral, Gauche, Laura, Schmidt, Jeremy, Höcker, Britta, Rieger, Susanne, Süsal, Caner, Tönshoff, Burkhard, Fichtner, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395307/ https://www.ncbi.nlm.nih.gov/pubmed/35166920 http://dx.doi.org/10.1007/s00467-022-05426-3

Ejemplares similares

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study
por: Süsal, Caner, et al.
Publicado: (2017)

Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies
por: Gold, Annika, et al.
Publicado: (2020)

Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
por: Kim, Jon Jin, et al.
Publicado: (2023)

Corrigendum: Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
por: Kim, Jon Jin, et al.
Publicado: (2023)

Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008)

Missing trial results: analysis of the current publication rate of studies in pediatric dialysis from 2003 to 2020
por: Patry, Christian, et al.
Publicado: (2022)

Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection
por: Wu, Qianni, et al.
Publicado: (2019)

Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era – Diagnosis, Immunological Risk Evaluation and Therapy
por: Slavcev, Antonij, et al.
Publicado: (2022)

The Immunological Basis of Liver Allograft Rejection
por: Ronca, Vincenzo, et al.
Publicado: (2020)

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine
por: Kamel, Mahmoud, et al.
Publicado: (2016)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection
por: Shen, Chia-Lin, et al.
Publicado: (2017)

Clinical Relevance of HLA Antibody Monitoring after Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2014)

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
por: Unterrainer, Christian, et al.
Publicado: (2021)

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
por: Suneja, Manish, et al.
Publicado: (2012)

Molecular Evidence of Pneumocystis Transmission in Pediatric Transplant Unit
por: Höcker, Britta, et al.
Publicado: (2005)

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
por: Spivey, Tara L, et al.
Publicado: (2011)

Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
por: Brunkhorst, Lena Caroline, et al.
Publicado: (2015)

Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study
por: Rubik, Jacek, et al.
Publicado: (2019)

Allorecognition by T Lymphocytes and Allograft Rejection
por: Marino, Jose, et al.
Publicado: (2016)

Therapies for Chronic Allograft Rejection
por: Kim, Min Young, et al.
Publicado: (2021)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?
por: Veltkamp, Denise M. J., et al.
Publicado: (2023)

Blood group-specific apheresis in combination with daratumumab as a rescue therapy of acute antibody-mediated rejection in a case of ABO- and human leukocyte antigen-incompatible kidney transplantation
por: Süsal, Can C, et al.
Publicado: (2023)

Corneal Allograft Rejection: Immunopathogenesis to Therapeutics
por: Qazi, Yureeda, et al.
Publicado: (2013)

The genetic determinants of renal allograft rejection
por: Hernandez‐Fuentes, Maria, et al.
Publicado: (2018)

Educational Case: Renal allograft rejection
por: Dai, Harrison, et al.
Publicado: (2022)

Relevant biomarkers of kidney allograft rejection
por: Loga, Luminița, et al.
Publicado: (2022)

Low Pre-Transplant Caveolin-1 Serum Concentrations Are Associated with Acute Cellular Tubulointerstitial Rejection in Kidney Transplantation
por: Emmerich, Florian, et al.
Publicado: (2021)

Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance
por: Nakano, Toshiaki, et al.
Publicado: (2012)

STXBP3 and GOT2 predict immunological activity in acute allograft rejection
por: Yao, Qinfan, et al.
Publicado: (2022)

Abstract: Belatacept and Rapamycin with Short-Term Use of Tacrolimus Delay Allograft Rejection in a Novel, Large Animal Vascularized Composite Allotransplantation Model
por: Elgendy, Tarek, et al.
Publicado: (2018)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Tacrolimus in preventing transplant rejection in Chinese patients – optimizing use
por: Li, Chuan-Jiang, et al.
Publicado: (2015)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy
por: Wen, Jiqiu, et al.
Publicado: (2016)

Editorial: Transplantation of Marginal Organs—Immunological Aspects and Therapeutic Perspectives
por: Süsal, Caner, et al.
Publicado: (2020)

Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection
por: Peyster, Eliot G., et al.
Publicado: (2018)

A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection
por: Coutance, Guillaume, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8e0tq2travrls9ao9han3m28t